X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
With this new funding, Nodus will be able to accelerate the development of its PARG programme in collaboration with the Lead Discovery Center GmbH, continue the development of novel DDR targets and further expand the Company’s portfolio.
Lead Product(s): Undisclosed
Therapeutic Area: Oncology Product Name: Undisclosed
Highest Development Status: PreclinicalProduct Type: Undisclosed
Partner/Sponsor/Collaborator: KHAN Technology Transfer Fund I
Deal Size: $2.9 million Upfront Cash: Undisclosed
Deal Type: Financing February 07, 2023
Details:
Nodus secures worldwide development and commercialization rights to Basilea’s PARG inhibitor (PARGi) programme – currently at the discovery stage - which has the potential to be a best-in-class treatment for molecularly defined patient sub-groups.
Lead Product(s): Undisclosed
Therapeutic Area: Oncology Product Name: Undisclosed
Highest Development Status: DiscoveryProduct Type: Small molecule
Recipient: Basilea Pharmaceutica
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Acquisition September 08, 2022
Details:
Under the terms of the agreement, Basilea entered into an asset purchase agreement with Nodus Oncology for Basilea’s novel poly (ADP-ribose) glycohydrolase (PARG) inhibitor discovery program.
Lead Product(s): Undisclosed
Therapeutic Area: Oncology Product Name: Undisclosed
Highest Development Status: DiscoveryProduct Type: Small molecule
Recipient: Basilea Pharmaceutica
Deal Size: $251.0 million Upfront Cash: Undisclosed
Deal Type: Divestment September 08, 2022
Details:
The financing will be used to expand and develop Nodus’ portfolio of first-in-class and best in class assets. LDC will act as the drug discovery arm of Nodus and participate in the development of all assets in Nodus’ pipeline.
Lead Product(s): Undisclosed
Therapeutic Area: Oncology Product Name: Undisclosed
Highest Development Status: DiscoveryProduct Type: Small molecule
Partner/Sponsor/Collaborator: Cumulus Oncology
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Financing September 06, 2022
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 
Market Place
